|Mr. Jody Aufrichtig||Co-Founder & Exec. Chairman||N/A||N/A||1974|
|Dr. Neil Maresky||Chief Exec. Officer||N/A||N/A||N/A|
|Mr. Alan Mark Friedman B.Com., Bcomm, Bproc Law||Co-Founder & Director||N/A||N/A||1972|
|Mr. Warwick Corden-Lloyd||Chief Financial Officer||N/A||N/A||1980|
|Mr. Mike Dacks||Chief Operating Officer||N/A||N/A||N/A|
|Dr. Justin Grant M.B.A., Ph.D., MBA||Chief Scientific Officer||N/A||N/A||N/A|
|Ms. Taryn Vos||Gen. Counsel||N/A||N/A||N/A|
|Dr. Dingle Spence B.Sc., M.D., MBBS||Chief Medical Officer of Psyence Jamaica & Member of Medical Advisory Board||N/A||N/A||N/A|
|Mr. Tony Budden||Chief Strategy Officer||N/A||N/A||N/A|
|Ms. Mary-Elizabeth Gifford||Exec. VP of Public Affairs & Corp. Social Responsibility||N/A||N/A||N/A|
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities in Canada and internationally. Its natural psilocybin is used for the long-term treatment of psychological trauma and its mental health consequences. The company also engages in developing therapeutic, hallucinogenic and subhallucinogenic dosing, and treatment protocols for the treatment of anxiety, depression, PTSD, grief, and bereavement. In addition, it focuses on the development of over-the-counter IP protected nutraceutical products for mental wellbeing. The company was founded in 2019 and is based in Toronto, Canada.
Psyence Group Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.